AMZEEQ
Minocycline
- Strength
- 40 mg/g
- Form
- Aerosol, Foam
- Class
- Tetracycline-class Drug
Journey Medical Corporation
Minocin
minocycline hydrochloride
Listed by Melinta Therapeutics, LLC
- Strength
- 100 mg/1
- Form
- Injection
- Route
- Intravenous
- Class
- Tetracycline-class Drug
What it contains
- Minocycline Hydrochloride 100 mg/1
FDA record
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Tetracycline-class Drug |
| Approval route | NDA — original brand approval |
| NDC code | 70842-160 |
| FDA application | NDA050444 |
| RxNorm concept | 207358 |
| Package sizes listed | 1 |
| Marketed since | April 2013 |
Other products containing Minocycline
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Arestin
Minocycline Hydrochloride
- Strength
- 1 mg/1
- Form
- Powder
- Class
- Tetracycline-class Drug
OraPharma, Inc.
EMROSI
Minocycline Hydrochloride Extended-Release
- Strength
- 40 mg/1
- Form
- Capsule
- Class
- Tetracycline-class Drug
Journey Medical Corporation
Minocycline Hydrochloride
- Strength
- 55 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- Tetracycline-class Drug
Bryant Ranch Prepack
Minocycline Hydrochloride
- Strength
- 50 mg/1
- Form
- Capsule
- Class
- Tetracycline-class Drug
Bryant Ranch Prepack
MINOCYCLINE HYDROCHLORIDE
- Strength
- 50 mg/1
- Form
- Tablet
- Class
- Tetracycline-class Drug
Bryant Ranch Prepack
Minocycline Hydrochloride
- Strength
- 100 mg/1
- Form
- Capsule
- Class
- Tetracycline-class Drug
Actavis Pharma, Inc.
Minocycline Hydrochloride
- Strength
- 65 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- Tetracycline-class Drug
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.